$67.71
-0.10 (-0.15%)
Techne Corp (NASDAQ:TECH)
CAPS Rating:
The Company and its subsidiaries are engaged in the development and manufacture of biotechnology products and hematology calibrators and controls.
The Company and its subsidiaries are engaged in the development and manufacture of biotechnology products and hematology calibrators and controls.